Abstract:Since most dominant human mutations are single nucleotide substitutions<a href="/articles/s41591-019-0500-9#ref-CR1">1</a>,<a href="/articles/s41591-019-0500-9#ref-CR2">2</a>, we explored gene editing strategies to disrupt dominant mutations efficiently and selectively without affecting wild-type alleles. However, single nucleotide discrimination can be difficult to achieve<a href="/articles/s41591-019-0500-9#ref-CR3">3</a> because commonly used endonucleases, such as Streptococcus pyogenes Cas9 (SpCas9), can tolerate up to seven mismatches between guide RNA (gRNA) and target DNA. Furthermore, the protospacer-adjacent motif (PAM) in some Cas9 enzymes can tolerate mismatches with the target DNA<a href="/articles/s41591-019-0500-9#ref-CR3">3</a>,<a href="/articles/s41591-019-0500-9#ref-CR4">4</a>. To circumvent these limitations, we screened 14 Cas9/gRNA combinations for specific and efficient disruption of a nucleotide substitution that causes the dominant progressive hearing loss, DFNA36. As a model for DFNA36, we used Beethoven mice<a href="/articles/s41591-019-0500-9#ref-CR5">5</a>, which harbor a point mutation in Tmc1, a gene required for hearing that encodes a pore-forming subunit of mechanosensory transduction channels in inner-ear hair cells<a href="/articles/s41591-019-0500-9#ref-CR6">6</a>. We identified a PAM variant of Staphylococcus aureus Cas9 (SaCas9-KKH) that selectively and efficiently disrupted the mutant allele, but not the wild-type Tmc1/TMC1 allele, in Beethoven mice and in a DFNA36 human cell line. Adeno-associated virus (AAV)-mediated SaCas9-KKH delivery prevented deafness in Beethoven mice up to one year post injection. Analysis of current ClinVar entries revealed that ~21% of dominant human mutations could be targeted using a similar approach.

Prevention of acquired sensorineural hearing loss in mice by in vivo <i>Htra2</i> gene editing

Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing

Specific knockdown of <i>Htra2</i> by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice

Genetic Correction of TRMU Allele Restored the Mitochondrial Dysfunction-Induced Deficiencies in Ipscs-Derived Hair Cells of Hearing-Impaired Patients.

Precise Detection of CRISPR-Cas9 Editing in Hair Cells in the Treatment of Autosomal Dominant Hearing Loss

Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice

In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing

Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor

Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

The Application of Genome Editing in Studying Hearing Loss.

Gene editing in a Myo6 semi-dominant mouse model rescues auditory function

Adeno-associated Virus Vector Enables Safe and Efficient Cas9 Activation in Neonatal and Adult Cas9 Knockin Murine Cochleae

Conditional overexpression of neuritin in supporting cells (SCs) mitigates hair cell (HC) damage and induces HC regeneration in the adult mouse cochlea after drug-induced ototoxicity

Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae

Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness

Template-independent genome editing in the <i>Pcdh15<SUP>av-3j</SUP></i> mouse, a model of human DFNB23 nonsyndromic deafness

Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss